News
Cancer Moonshot Expert Panel, Including UCSF Researchers, Delivers 10 Recommendations
Ten recommendations from a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates – including two UC San Francisco researchers – have been approved to help guide the National Cancer Moonshot Initiative. UCSF researchers Mitchel Berger, MD, and Jeffrey Bluestone, PhD, were
UCSF Investigators Reflect on Dream Team Collaborations as Stand Up to Cancer Telethon Approaches
On September 9 th, millions of people across the United States and Canada are expected to tune into the fifth biennial Stand Up to Cancer broadcast raising money for cancer research. Since 2008, SU2C has raised more than $370 million and dedicates 100% of funds raised to support collaborative
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy, Study Finds
Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco researcher. In the study, reported Aug. 24, 2016, in The New England
Frequency of Breast Cancer Screening is Best Guided by Both Risk, Breast Density, Says Study
The ideal interval for breast cancer screening depends on combined assessments of each woman’s breast cancer risk and her breast density, according to a new study led by UC San Francisco and University of Wisconsin (UW) researchers. The research team, members of two nationwide breast cancer research
Clearing the Air on E-cigarettes: Q&A with Dr. Stanton Glantz
The FDA earlier this month began banning the sale of electronic nicotine devices (ENDs), also called e-cigarettes, to people younger than 18. The new rules also require a photo ID to purchase tobacco products, prohibit free samples, and selling tobacco products in vending machines. Also, all ENDs
Immune-Cell Population Predicts Immunotherapy Response in Melanoma
The abundance of a subtype of white blood cells in melanoma tumors can predict whether or not patients will respond to a form of cancer immunotherapy known as checkpoint blockade, according to a new study led by UC San Francisco researchers and physicians. The research offers the beginnings of a
UCSF Medical Center Ranked 7th Best Hospital in the U.S. for 2016-17
UCSF Medical Center has been named among the nation’s premier medical institutions for the 15 thconsecutive year, ranking as the seventh best hospital in the country in U.S. News & World Report’s 2016-2017 Best Hospitals survey. UCSF received elite Honor Roll status for exceptional performance in 15